BlossomHill Therapeutics Funding & Investors
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
bhtherapeutics.comTotal Amount Raised: $173,000,000
BlossomHill Therapeutics Funding Rounds
Series B
$100,000,000
Series B Investors
Colt VenturesCormorant Asset ManagementOrbiMed AdvisorsHercules PartnersH&D Asset ManagementVivo CapitalPlaisance Capital ManagementSeries A
$71,000,000
Series A Investors
Cormorant Asset ManagementOrbiMed AdvisorsVivo CapitalHercules Bioventure PartnersPre Seed
$2,000,000
Funding info provided by Diffbot.